Perrigo to buy biotech Elan in $8.6 billion deal

Drug maker Perrigo has agreed to buy Irish biotech firm Elan in the latest pharmaceutical-industry deal motivated at least in part by reducing corporate taxes.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.